Skip to main content
Erschienen in: Clinical and Translational Oncology 4/2013

01.04.2013 | Brief Research Article

Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients

verfasst von: Xu Liang, Jie Zhang, Yulin Zhu, Yuanli Lu, Xinna Zhou, Zheng Wang, Jing Yu, Ying Yan, Lijun Di, Li Che, Hanfang Jiang, Bin Shao, Xiaoli Wang, Huabing Yang, Herbert Kim Lyerly, Jun Ren

Erschienen in: Clinical and Translational Oncology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Aim

This study was designed to explore the genetic polymorphism of IL-10 (−1082A/G, −592A/C, −819T/C), TNF-α (−308G/A) with susceptibility to docetaxel-induced liver injury (DILI) in Chinese breast cancer patients.

Methods

The targeted genetic polymorphisms of IL10-1082G/A, IL10-592A/C, IL10-819T/C, TNF-308G/A from 40 patients with DILI were assayed by matrix-assisted laser desorption/ionization-time of flight of Sequenom.

Results

AA genotype of IL10-592 and TT of IL10-819 significantly increased incidence of DILI (P = 0.005, OR = 3.137). No differences of TNF gene polymorphism between the two groups were seen.

Conclusion

The genetic polymorphism of the IL10-592A/C AA genotype and IL10-819T/C TT genotype was predominantly conferred to the incidence of docetaxel-induced liver injury.
Literatur
1.
Zurück zum Zitat Temple RJ, Himmel MH (2002) Safety of newly approved drugs: implications for prescribing. JAMA 287:2273–2275PubMedCrossRef Temple RJ, Himmel MH (2002) Safety of newly approved drugs: implications for prescribing. JAMA 287:2273–2275PubMedCrossRef
2.
Zurück zum Zitat Wang Z, Liang X, Yu J et al (2012) Non-genetic risk factors and predicting efficacy for docetaxel-drug-induced liver injury among metastatic breast cancer patients. J Gastroenterol Hepatol 27:1348–1352PubMedCrossRef Wang Z, Liang X, Yu J et al (2012) Non-genetic risk factors and predicting efficacy for docetaxel-drug-induced liver injury among metastatic breast cancer patients. J Gastroenterol Hepatol 27:1348–1352PubMedCrossRef
3.
4.
Zurück zum Zitat Aithal GP, Ramsay L, Daly AK et al (2004) Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39:1430–1440PubMedCrossRef Aithal GP, Ramsay L, Daly AK et al (2004) Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39:1430–1440PubMedCrossRef
5.
Zurück zum Zitat Wanidworanun C, Strober W (1993) Predominant role of tumor necrosis factor-alpha in human monocyte IL10 synthesis. J Immunol 151:6853–6861PubMed Wanidworanun C, Strober W (1993) Predominant role of tumor necrosis factor-alpha in human monocyte IL10 synthesis. J Immunol 151:6853–6861PubMed
6.
Zurück zum Zitat D’Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNF A promoter region. Immunogenetics 39:150–154PubMed D’Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNF A promoter region. Immunogenetics 39:150–154PubMed
7.
Zurück zum Zitat Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46:1323–1330PubMedCrossRef Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46:1323–1330PubMedCrossRef
8.
Zurück zum Zitat Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef
9.
Zurück zum Zitat Ozer JS, Dieterle F, Troth S et al (2010) A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol 28:486–494PubMedCrossRef Ozer JS, Dieterle F, Troth S et al (2010) A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol 28:486–494PubMedCrossRef
10.
Zurück zum Zitat Pulitano C, Sitia G, Aldrighetti L et al (2006) Reduced severity of liver ischemia/reperfusion injury following hepatic resection in humans is associated with enhanced intrahepatic expression of Th2 cytokines. Hepatol Res 36:20–26PubMedCrossRef Pulitano C, Sitia G, Aldrighetti L et al (2006) Reduced severity of liver ischemia/reperfusion injury following hepatic resection in humans is associated with enhanced intrahepatic expression of Th2 cytokines. Hepatol Res 36:20–26PubMedCrossRef
11.
Zurück zum Zitat Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI (1995) Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133:43–52PubMedCrossRef Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI (1995) Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133:43–52PubMedCrossRef
12.
Zurück zum Zitat Pachkoria K, Lucena MI, Crespo E et al (2008) Analysis of IL10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome. J Hepatol 49:107–114PubMedCrossRef Pachkoria K, Lucena MI, Crespo E et al (2008) Analysis of IL10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome. J Hepatol 49:107–114PubMedCrossRef
13.
Zurück zum Zitat Hoffmann SC, Stanley EM, Cox ED et al (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2:560–567PubMedCrossRef Hoffmann SC, Stanley EM, Cox ED et al (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2:560–567PubMedCrossRef
14.
Zurück zum Zitat Farhat K, Hassen E, Gabbouj S, Bouaouina N, Chouchane L (2008) Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma. Int J Immunogenet 35:197–205PubMedCrossRef Farhat K, Hassen E, Gabbouj S, Bouaouina N, Chouchane L (2008) Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma. Int J Immunogenet 35:197–205PubMedCrossRef
Metadaten
Titel
Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients
verfasst von
Xu Liang
Jie Zhang
Yulin Zhu
Yuanli Lu
Xinna Zhou
Zheng Wang
Jing Yu
Ying Yan
Lijun Di
Li Che
Hanfang Jiang
Bin Shao
Xiaoli Wang
Huabing Yang
Herbert Kim Lyerly
Jun Ren
Publikationsdatum
01.04.2013
Verlag
Springer Milan
Erschienen in
Clinical and Translational Oncology / Ausgabe 4/2013
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0936-6

Weitere Artikel der Ausgabe 4/2013

Clinical and Translational Oncology 4/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.